Business Context and Reporting Period
This Form 8-K Current Report was filed by GoodRx Holdings, Inc. on April 20, 2022. The filing addresses a specific corporate governance event regarding the appointment of a senior officer rather than a periodic financial reporting cycle.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Romin Nabiey as the Company's Chief Accounting Officer, effective immediately on April 20, 2022. Mr. Nabiey succeeds Karsten Voermann in this specific role, though Mr. Voermann continues to serve as the Company's Chief Financial Officer and principal financial officer.
Management Commentary and Risks
Management noted that no new or amended compensation has been determined for Mr. Nabiey in connection with this appointment. The filing includes a contingency that if material new or amended compensation is determined, the Company will amend this report within four business days. No other risks or unusual items were disclosed in this specific filing.
Investor Verification Checklist
- Verify the effective date of Romin Nabiey's appointment as Chief Accounting Officer (April 20, 2022).
- Confirm that Karsten Voermann retains his title as Chief Financial Officer.
- Monitor for any future amendments to this 8-K regarding compensation for Mr. Nabiey.
- Review the Company's most recent 10-K or 10-Q for actual financial performance metrics, as they are absent from this filing.